Beginning of the closed period before the publication of half-year results
21.05.2026
See also
Synektik shareholders have unanimously approved the division of the company and spinoff of the cardiotracer project to Syn2bio
- Corporate news
- Investor relations
Synektik edges closer to demerger as Syn2bio files prospectus with KNF
- Corporate news
- Investor relations
Synektik one step closer to planned division
- Corporate news
- Investor relations